Back to AI Alyeska Investment Group, L.P.

CLYMCLYM

3 quarters

Position history for AIAlyeska Investment Group, L.P.'s holdings in CLIMB BIO INC

No. Alyeska Investment Group exited its CLYM (Climb Bio) position in Q4 2025. Its Q3 2025 13F listed 485,364 shares worth $975,582. Alyeska Investment Group first reported CLYM in Q2 2025 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$601,851

Total Shares Change

-485,364

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$4.00
0
2025-Q3
Unchanged
485,364
0.0%
$975,5820.0%$2.01
0
2025-Q2
New
485,364
—
$601,8510.0%$1.24
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used